In conclusion, CER, Apo-A1, LN, PLT, HDL-C, TG, and Sex were identified as independent risk factors for advanced hepatic fibrosis in WD patients undergoing long-term maintenance therapy. The gene discussed is APOA1; the disease is Hepatic fibrosis.